Development of an early or core value dossier with MTRC

04

Oct 2022

Every innovative technology has the challenge to communicate its value to different stakeholders. Why this health care problem is important (mortality, morbidity, impact on the quality of life, cost-of-illness)? What are the current treatment options and what are their limitations? What is the size of the population with high unmet needs? What is the proposed novel solution? Is it safe and effective? What are the economic consequences to the hospital and health care system? What are the organizational requirements for the introduction of a novel method?

Historically, these questions were answered by separate publications in peer-reviewed journals and marketing materials. However, they are typically not comprehensive enough, lack important information, and are too unstructured to support discussion with clinicians, reimbursement authorities, and payers.

The modern answer to the challenge of summarizing and presenting the value of the technology is the value dossier. A value dossier is a document of a certain structure that summarizes in a comprehensive and unbiased way all value-related messages for medical technology. The document is also used as a source of information for any reimbursement-related activities: from supporting local business cases to application to the national HTA.

There are two formats of the value dossier: early dossier - a relatively short (15-20 pages) document, based on a systematic but limited search with a focus on the key messages and data; core value dossier is a more comprehensive document (typically about 60-100 pages plus supplements) that covers a larger number of topics.

MTRC can provide support with the development of both early and core value dossiers. Typically, a dossier is developed either from a global or European perspective.

Learn more about our approach here

The latest related news

20

Mar 2023

Since 2017 MTRC has provided reimbursement and HEOR services for the medical device and IVD industry in Europe. We specialize in Pan-European projects and worked in 34 countries in Europe. In this post, we summarized statistics about our experience with reimbursement projects in different EU countries. Three leading countries are England (273 projects), Germany (247 projects), and France (203 projects).

Read more

20

Mar 2023

MTRC is the leading provider of market access services in Europe. Since 2017 we have accomplished 700+ projects in Europe. We provide regular consulting services to 56% of top 30 med tech companies and multiple SMEs. The typical scope of model adaptation includes adjustment of epidemiological data, validation of comparator, an adaptation of resource use and cost data, and search for local utility data. MTRC has a unique ability to work on model adaptations due to its unparalleled knowledge of payment systems in 34 European countries. We worked on model adaptations in Belgium, Denmark, Finland, France, Germany, Italy, Norway, the Netherlands, Poland, Russia, Spain, Sweden, and the UK.

Read more

02

Mar 2023

Australia is a complex country from a market access perspective. The main aspects of the healthcare system are centralized, with minor differences among states and territories. Hospitals are financed by both the states/territories and the Australian Government, and they receive budgets adjusted for DRG and outpatient activities. Physician activities are reimbursed separately according to the Medicare Benefits Schedule. HTA framework is incorporated in the process of inclusion of new services in the Medicare Benefits Schedule.

Read more

01

Feb 2023

Canada is a complex country from a market access perspective. The healthcare system is decentralized, with provinces taking the leading role in the organization and financing of services. While most of the provinces use a simple global budget model (based on historical costs) to finance hospital activities, in largest provinces (Ontario and Quebec), casemix data reported via the DRG system also influences the budget determination. Physician activities are reimbursed separately according to provincial fee schedules. The market access landscape is complicated by the presence of national and provincial HTA frameworks and provincial funding frameworks.

Read more

30

Jan 2023

MTRC is looking for an experienced systematic reviewer to work on evidence synthesis projects (systematic reviews, value dossiers) in the field of medical devices.

Read more